首页 > 最新文献

Nephron Experimental Nephrology最新文献

英文 中文
Multiple mechanisms in renal artery stenosis-induced renal interstitial fibrosis. 肾动脉狭窄致肾间质纤维化的多种机制。
Pub Date : 2014-01-01 Epub Date: 2014-11-08 DOI: 10.1159/000366481
Rui Cui, Xiao Chen, Lei Peng, Jing Ma, Dan Zhu, Tong Li, Qiuju Wei, Bing Li

Background/aims: Renal artery stenosis (RAS), which may lead to renal fibrosis, is a common cause of end-stage renal disease in elderly patients. However, the potential mechanisms leading to the development of renal fibrosis and atrophy have not been clarified.

Methods: A two-kidney, one-clip Goldblatt mouse model was established in the present study. Blood pressure, morphological and pathological alterations were examined on days 7, 14, and 28 after surgery. Peritubular capillary loss and pericyte changes after injury were evaluated. Inflammatory macrophage infiltration and Wnt/β-catenin signaling were also investigated.

Results: A significant increase in blood pressure and obvious renal atrophy were observed on days 7, 14, and 28 after surgery. Following surgery, the clipped kidneys developed aggravated interstitial fibrosis and tubular epithelial injury over time. Moreover, RAS induced obvious peritubular capillary loss and inflammatory macrophage infiltration. Increased pericyte number was found in the clipped kidneys, but these cells detached from the endothelial cells and migrated to the interstitium. Wnt/β-catenin signaling was also significantly upregulated in the clipped kidneys after surgery.

Conclusion: Our study provides a novel insight into the mechanisms linking peritubular capillary loss and pericyte changes in RAS-induced renal fibrosis. Our findings also suggest that inflammatory macrophages and Wnt/β-catenin signaling participate in these pathological processes. Therefore, multi-target therapeutic strategies may significantly contribute to the prevention of renal interstitial fibrosis and the preservation of renal function in patients with RAS.

背景/目的:肾动脉狭窄(RAS)可导致肾纤维化,是老年患者终末期肾脏疾病的常见原因。然而,导致肾纤维化和肾萎缩的潜在机制尚未明确。方法:建立双肾单夹Goldblatt小鼠模型。术后第7、14、28天检测血压、形态学及病理改变。观察损伤后小管周围毛细血管损失及周细胞变化。炎性巨噬细胞浸润和Wnt/β-catenin信号传导也被研究。结果:术后第7、14、28天血压明显升高,肾明显萎缩。手术后,随着时间的推移,夹住的肾脏间质纤维化和小管上皮损伤加重。RAS引起明显的小管周围毛细血管损失和炎性巨噬细胞浸润。在切除的肾脏中发现周细胞数量增加,但这些细胞脱离内皮细胞并迁移到间质。Wnt/β-catenin信号在手术后切除的肾脏中也显著上调。结论:我们的研究为ras诱导的肾纤维化中小管周围毛细血管损失和周细胞变化的机制提供了新的见解。我们的研究结果还表明炎症性巨噬细胞和Wnt/β-catenin信号参与了这些病理过程。因此,多靶点治疗策略可能对RAS患者肾间质纤维化的预防和肾功能的保护有重要作用。
{"title":"Multiple mechanisms in renal artery stenosis-induced renal interstitial fibrosis.","authors":"Rui Cui,&nbsp;Xiao Chen,&nbsp;Lei Peng,&nbsp;Jing Ma,&nbsp;Dan Zhu,&nbsp;Tong Li,&nbsp;Qiuju Wei,&nbsp;Bing Li","doi":"10.1159/000366481","DOIUrl":"https://doi.org/10.1159/000366481","url":null,"abstract":"<p><strong>Background/aims: </strong>Renal artery stenosis (RAS), which may lead to renal fibrosis, is a common cause of end-stage renal disease in elderly patients. However, the potential mechanisms leading to the development of renal fibrosis and atrophy have not been clarified.</p><p><strong>Methods: </strong>A two-kidney, one-clip Goldblatt mouse model was established in the present study. Blood pressure, morphological and pathological alterations were examined on days 7, 14, and 28 after surgery. Peritubular capillary loss and pericyte changes after injury were evaluated. Inflammatory macrophage infiltration and Wnt/β-catenin signaling were also investigated.</p><p><strong>Results: </strong>A significant increase in blood pressure and obvious renal atrophy were observed on days 7, 14, and 28 after surgery. Following surgery, the clipped kidneys developed aggravated interstitial fibrosis and tubular epithelial injury over time. Moreover, RAS induced obvious peritubular capillary loss and inflammatory macrophage infiltration. Increased pericyte number was found in the clipped kidneys, but these cells detached from the endothelial cells and migrated to the interstitium. Wnt/β-catenin signaling was also significantly upregulated in the clipped kidneys after surgery.</p><p><strong>Conclusion: </strong>Our study provides a novel insight into the mechanisms linking peritubular capillary loss and pericyte changes in RAS-induced renal fibrosis. Our findings also suggest that inflammatory macrophages and Wnt/β-catenin signaling participate in these pathological processes. Therefore, multi-target therapeutic strategies may significantly contribute to the prevention of renal interstitial fibrosis and the preservation of renal function in patients with RAS.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"128 1-2","pages":"57-66"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000366481","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32818833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells. 肾损伤的细胞治疗:不同的选择和机制——间充质干细胞和羊水干细胞。
Pub Date : 2014-01-01 Epub Date: 2014-05-19 DOI: 10.1159/000360667
Marina Morigi, Paolo De Coppi

Background: Acute kidney injury (AKI) is emerging as a public health problem in developing and developed countries. It affects up to 7% of hospitalized patients, with a higher prevalence in critical care units. Despite major advances in preventive strategies and support measures, the mortality rate among patients remains higher than 50%. Several pharmacological approaches to improve renal function and survival after an AKI episode have been largely unsuccessful in clinical practice.

Summary: Stem cell-based therapy has provided new hopes of innovative interventions to enhance the limited capability of kidney regeneration in AKI. An important target for cell therapy is represented by tubular epithelial cells which after acute ischemic or toxic insults undergo dysfunction and detachment. Among adult stem cells, mesenchymal stromal/stem cells (MSC) are an attractive therapeutic tool by virtue of their unique biological properties, tropism for damaged tissues, and proregenerative capacity. In the present review, we discuss the mechanisms underlying the renoprotective effects of therapies with stem cells of different origins in preclinical models of AKI by evaluating new modalities by which MSC interact with damaged cells via the release of soluble factors and exosomes/microvesicles. Several biological effects, including antiapoptotic, promitogenic, immunomodulatory, and anti-inflammatory activities, have been analyzed in renal tissue of AKI animals receiving stem cell treatments. The mechanisms of stem cell homing and engraftment to sites of tissue damage have also been discussed.

Key messages: The translation of preclinical data on stem cells into effective and safe new modalities of care is still limited, and further studies are needed before their application in patients with AKI.

背景:急性肾损伤(AKI)正在成为发展中国家和发达国家的一个公共卫生问题。它影响高达7%的住院患者,在重症监护病房患病率更高。尽管在预防战略和支助措施方面取得了重大进展,但患者死亡率仍然高于50%。几种改善AKI发作后肾功能和生存的药理学方法在临床实践中大多不成功。摘要:干细胞治疗为创新干预措施提供了新的希望,以增强AKI患者有限的肾脏再生能力。细胞治疗的一个重要靶点是小管上皮细胞,它们在急性缺血或毒性损伤后会发生功能障碍和脱落。在成体干细胞中,间充质基质/干细胞(MSC)因其独特的生物学特性、对受损组织的亲和性和促再生能力而成为一种有吸引力的治疗工具。在本综述中,我们通过评估MSC通过可溶性因子和外泌体/微囊泡的释放与受损细胞相互作用的新模式,讨论了AKI临床前模型中不同来源干细胞治疗的肾保护作用机制。一些生物学效应,包括抗凋亡、促生、免疫调节和抗炎活性,已经在接受干细胞治疗的AKI动物肾组织中进行了分析。干细胞归巢和移植到组织损伤部位的机制也进行了讨论。关键信息:将干细胞的临床前数据转化为有效和安全的新护理模式仍然有限,在将其应用于AKI患者之前需要进一步的研究。
{"title":"Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells.","authors":"Marina Morigi,&nbsp;Paolo De Coppi","doi":"10.1159/000360667","DOIUrl":"https://doi.org/10.1159/000360667","url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) is emerging as a public health problem in developing and developed countries. It affects up to 7% of hospitalized patients, with a higher prevalence in critical care units. Despite major advances in preventive strategies and support measures, the mortality rate among patients remains higher than 50%. Several pharmacological approaches to improve renal function and survival after an AKI episode have been largely unsuccessful in clinical practice.</p><p><strong>Summary: </strong>Stem cell-based therapy has provided new hopes of innovative interventions to enhance the limited capability of kidney regeneration in AKI. An important target for cell therapy is represented by tubular epithelial cells which after acute ischemic or toxic insults undergo dysfunction and detachment. Among adult stem cells, mesenchymal stromal/stem cells (MSC) are an attractive therapeutic tool by virtue of their unique biological properties, tropism for damaged tissues, and proregenerative capacity. In the present review, we discuss the mechanisms underlying the renoprotective effects of therapies with stem cells of different origins in preclinical models of AKI by evaluating new modalities by which MSC interact with damaged cells via the release of soluble factors and exosomes/microvesicles. Several biological effects, including antiapoptotic, promitogenic, immunomodulatory, and anti-inflammatory activities, have been analyzed in renal tissue of AKI animals receiving stem cell treatments. The mechanisms of stem cell homing and engraftment to sites of tissue damage have also been discussed.</p><p><strong>Key messages: </strong>The translation of preclinical data on stem cells into effective and safe new modalities of care is still limited, and further studies are needed before their application in patients with AKI.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 2","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000360667","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32361503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 44
Can kidney regeneration be visualized? 肾脏再生能可视化吗?
Pub Date : 2014-01-01 Epub Date: 2014-05-19 DOI: 10.1159/000360673
János Peti-Peterdi, James L Burford, Matthias J Hackl

Background: Various cell types, including podocytes and parietal epithelial cells, play important roles in the development and progression of glomerular kidney diseases, albuminuria, and glomerulosclerosis. Besides their role in renal pathologies, glomerular cells have emerging new functions in endogenous repair mechanisms. A better understanding of the dynamics of the glomerular environment and cellular composition in an intact living kidney is critically important for the development of new regenerative therapeutic strategies for kidney diseases. However, progress in this field has been hampered by the lack of in vivo research tools.

Summary: This review summarizes the current state-of-the-art in the application of the unique intravital imaging technology of multiphoton fluorescence microscopy for the dynamic visualization of glomerular structure and function over time in the intact, living kidney. Recently, this imaging approach in combination with transgenic mouse models allowed tracking of the fate of individual glomerular cells in vivo over several days and depicted the highly dynamic nature of the glomerular environment, particularly in disease conditions.

Key messages: The technology is ready and available for future intravital imaging studies investigating new glomerular regenerative approaches in animal models.

背景:多种细胞类型,包括足细胞和壁上皮细胞,在肾小球肾病、蛋白尿和肾小球硬化的发生和发展中起重要作用。除了在肾脏病理中发挥作用外,肾小球细胞在内源性修复机制中也具有新的功能。更好地了解完整活肾中肾小球环境和细胞组成的动力学对于开发新的肾脏疾病再生治疗策略至关重要。然而,由于缺乏体内研究工具,这一领域的进展受到阻碍。摘要:本文综述了多光子荧光显微镜独特的活体成像技术在完整活体肾脏肾小球结构和功能随时间变化动态可视化中的应用现状。最近,这种成像方法与转基因小鼠模型相结合,可以在体内数天内跟踪单个肾小球细胞的命运,并描述肾小球环境的高度动态性质,特别是在疾病条件下。关键信息:该技术已准备就绪,可用于未来动物模型中肾小球再生新方法的活体成像研究。
{"title":"Can kidney regeneration be visualized?","authors":"János Peti-Peterdi,&nbsp;James L Burford,&nbsp;Matthias J Hackl","doi":"10.1159/000360673","DOIUrl":"https://doi.org/10.1159/000360673","url":null,"abstract":"<p><strong>Background: </strong>Various cell types, including podocytes and parietal epithelial cells, play important roles in the development and progression of glomerular kidney diseases, albuminuria, and glomerulosclerosis. Besides their role in renal pathologies, glomerular cells have emerging new functions in endogenous repair mechanisms. A better understanding of the dynamics of the glomerular environment and cellular composition in an intact living kidney is critically important for the development of new regenerative therapeutic strategies for kidney diseases. However, progress in this field has been hampered by the lack of in vivo research tools.</p><p><strong>Summary: </strong>This review summarizes the current state-of-the-art in the application of the unique intravital imaging technology of multiphoton fluorescence microscopy for the dynamic visualization of glomerular structure and function over time in the intact, living kidney. Recently, this imaging approach in combination with transgenic mouse models allowed tracking of the fate of individual glomerular cells in vivo over several days and depicted the highly dynamic nature of the glomerular environment, particularly in disease conditions.</p><p><strong>Key messages: </strong>The technology is ready and available for future intravital imaging studies investigating new glomerular regenerative approaches in animal models.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 2","pages":"86"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000360673","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32361999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Cell therapy for kidney injury: different options and mechanisms--kidney progenitor cells. 肾损伤的细胞治疗:不同的选择和机制——肾祖细胞。
Pub Date : 2014-01-01 Epub Date: 2014-05-19 DOI: 10.1159/000360668
Kenji Osafune

Background: Since no specific or radical treatments have yet been established for acute kidney injury (AKI), the development of cell transplantation therapy using renal progenitors is desirable as a new therapeutic option for AKI. The recent advances in developmental biology, stem cell biology, and nephrology have led to an increased availability of renal progenitors from multiple sources.

Summary: Four main sources of renal progenitors have been described so far: isolation from (1) embryonic or (2) adult kidneys, (3) directed differentiation of pluripotent stem cells such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), and (4) cellular reprogramming of fully differentiated adult renal cells. Renal progenitors from adult kidneys may not be equivalent to those from embryonic kidneys, and they contain several different cell populations identified by various methods. The methods used for the directed differentiation of ESCs/iPSCs and reprogramming of differentiated adult renal cells into renal progenitors have not been fully established. The therapeutic effects of progenitor cell transplantation in AKI animal models have been examined in a small number of reports using renal progenitors from adult kidneys, while no reports have described the therapeutic potential of renal progenitors from other sources.

Key messages: Renal progenitor transplantation might provide a novel therapeutic strategy for AKI. Further research efforts toward the clinical application of this strategy are needed, including a detailed characterization of embryonic or adult renal progenitors and the development of in vitro expansion methods and therapeutically effective transplantation methods for these cell types. More experience and knowledge should be accumulated regarding the directed differentiation of pluripotent stem cells and cellular reprogramming to generate renal progenitor cells.

背景:由于急性肾损伤(AKI)尚未建立特异性或根治性的治疗方法,因此利用肾祖细胞进行细胞移植治疗是一种治疗AKI的新选择。最近在发育生物学、干细胞生物学和肾脏病学方面的进展已经导致肾祖细胞从多种来源的可用性增加。到目前为止,已经描述了肾祖细胞的四个主要来源:从(1)胚胎或(2)成人肾脏中分离,(3)多能干细胞(如胚胎干细胞(ESCs)和诱导多能干细胞(iPSCs))的定向分化,以及(4)完全分化的成人肾细胞的细胞重编程。来自成人肾脏的肾祖细胞可能不等同于来自胚胎肾脏的肾祖细胞,它们包含几种不同的细胞群,通过各种方法鉴定。ESCs/iPSCs定向分化和分化成肾细胞重编程成肾祖细胞的方法尚未完全建立。祖细胞移植在AKI动物模型中的治疗效果已经在少数使用成人肾脏祖细胞的报道中进行了研究,而没有报道描述来自其他来源的肾祖细胞的治疗潜力。关键信息:肾祖细胞移植可能为AKI提供一种新的治疗策略。这一策略的临床应用需要进一步的研究,包括胚胎或成人肾祖细胞的详细特征,以及这些细胞类型的体外扩增方法和治疗有效移植方法的发展。在多能干细胞定向分化和细胞重编程生成肾祖细胞方面,需要积累更多的经验和知识。
{"title":"Cell therapy for kidney injury: different options and mechanisms--kidney progenitor cells.","authors":"Kenji Osafune","doi":"10.1159/000360668","DOIUrl":"https://doi.org/10.1159/000360668","url":null,"abstract":"<p><strong>Background: </strong>Since no specific or radical treatments have yet been established for acute kidney injury (AKI), the development of cell transplantation therapy using renal progenitors is desirable as a new therapeutic option for AKI. The recent advances in developmental biology, stem cell biology, and nephrology have led to an increased availability of renal progenitors from multiple sources.</p><p><strong>Summary: </strong>Four main sources of renal progenitors have been described so far: isolation from (1) embryonic or (2) adult kidneys, (3) directed differentiation of pluripotent stem cells such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), and (4) cellular reprogramming of fully differentiated adult renal cells. Renal progenitors from adult kidneys may not be equivalent to those from embryonic kidneys, and they contain several different cell populations identified by various methods. The methods used for the directed differentiation of ESCs/iPSCs and reprogramming of differentiated adult renal cells into renal progenitors have not been fully established. The therapeutic effects of progenitor cell transplantation in AKI animal models have been examined in a small number of reports using renal progenitors from adult kidneys, while no reports have described the therapeutic potential of renal progenitors from other sources.</p><p><strong>Key messages: </strong>Renal progenitor transplantation might provide a novel therapeutic strategy for AKI. Further research efforts toward the clinical application of this strategy are needed, including a detailed characterization of embryonic or adult renal progenitors and the development of in vitro expansion methods and therapeutically effective transplantation methods for these cell types. More experience and knowledge should be accumulated regarding the directed differentiation of pluripotent stem cells and cellular reprogramming to generate renal progenitor cells.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 2","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000360668","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32361504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy. 来氟米特和苯那普利在链状佐菌素诱导的糖尿病肾病中的协同作用。
Pub Date : 2014-01-01 Epub Date: 2014-05-16 DOI: 10.1159/000362556
Hua Jin, Shang Guo Piao, Ji Zhe Jin, Ying Shun Jin, Zhen Hua Cui, Hai Feng Jin, Hai Lan Zheng, Jin Ji Li, Yu Ji Jiang, Chul Woo Yang, Can Li

Background: Leflunomide (LEF) and benazepril have renoprotective effects on diabetic nephropathy (DN) through their anti-inflammatory and anti-fibrotic activities. This study investigated whether combined treatment using LEF and benazepril affords superior protection compared with the respective monotherapies.

Methods: Diabetes was induced with streptozotocin (STZ, 65 mg/kg) by intraperitoneal injection in male Wistar rats. Two weeks after STZ injection, diabetic rats were treated daily for 12 weeks with LEF (10 mg/kg), benazepril (10 mg/kg), or a combination of both. Basic parameters (body weight, fasting blood glucose level, and 24 h urinary protein excretion), histopathology, inflammatory [inflammatory cell infiltration (ED-1), monocyte chemoattractant protein-1 (MCP-1), and Toll-like receptor-2 (TLR-2)] and glomerulosclerotic factors [transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF)], and oxidative stress (8-hydroxy-2'-deoxyguanosine, 8-OHdG) were studied.

Results: Benazepril or LEF treatment significantly prevented body weight loss and 24 h urinary protein excretion induced by diabetes; combined treatment with LEF and benazepril further improved these parameters compared with giving each drug alone (all p < 0.01). Increased expression of inflammatory (MCP-1 and TLR-2) and glomerulosclerotic (TGF-β1 and CTGF) factors in diabetic rat kidney was reduced by treatment with either LEF or benazepril and was further reduced by the combined administration of the two drugs (p < 0.01). These effects were accompanied by suppression of urinary 8-OHdG excretion. There was no significant between-group difference in blood glucose level.

Conclusions: LEF treatment lessens DN, and combined treatment with LEF and benazepril provides synergistic effects in preventing DN.

背景:来氟米特(LEF)和苯那普利(benazepril)通过抗炎和抗纤维化作用对糖尿病肾病(DN)具有肾保护作用。本研究调查了LEF和苯那普利联合治疗是否比单独治疗提供更好的保护。方法:采用链脲佐菌素(STZ, 65 mg/kg)腹腔注射诱导雄性Wistar大鼠糖尿病。STZ注射后2周,糖尿病大鼠每天给予LEF (10 mg/kg)、苯那普利(10 mg/kg)或两者联合治疗12周。研究基本参数(体重、空腹血糖水平、24 h尿蛋白排泄)、组织病理学、炎症[炎性细胞浸润(ED-1)、单核细胞趋化蛋白-1 (MCP-1)、toll样受体-2 (TLR-2)]、肾小球硬化因子[转化生长因子-β1 (TGF-β1)、结缔组织生长因子(CTGF)]、氧化应激(8-羟基-2′-脱氧鸟苷,8-OHdG)]。结果:苯那普利或LEF治疗可显著预防糖尿病所致体重下降和24 h尿蛋白排泄;与单用两种药物相比,LEF联合贝那普利进一步改善了这些指标(p < 0.01)。LEF或苯那普利均可降低糖尿病大鼠肾脏炎症因子(MCP-1、TLR-2)和肾小球硬化因子(TGF-β1、CTGF)表达的升高,两药合用可进一步降低其表达(p < 0.01)。这些影响伴随着尿8-OHdG排泄的抑制。两组间血糖水平无显著差异。结论:LEF治疗可减轻DN, LEF与苯那普利联用对DN有协同预防作用。
{"title":"Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy.","authors":"Hua Jin,&nbsp;Shang Guo Piao,&nbsp;Ji Zhe Jin,&nbsp;Ying Shun Jin,&nbsp;Zhen Hua Cui,&nbsp;Hai Feng Jin,&nbsp;Hai Lan Zheng,&nbsp;Jin Ji Li,&nbsp;Yu Ji Jiang,&nbsp;Chul Woo Yang,&nbsp;Can Li","doi":"10.1159/000362556","DOIUrl":"https://doi.org/10.1159/000362556","url":null,"abstract":"<p><strong>Background: </strong>Leflunomide (LEF) and benazepril have renoprotective effects on diabetic nephropathy (DN) through their anti-inflammatory and anti-fibrotic activities. This study investigated whether combined treatment using LEF and benazepril affords superior protection compared with the respective monotherapies.</p><p><strong>Methods: </strong>Diabetes was induced with streptozotocin (STZ, 65 mg/kg) by intraperitoneal injection in male Wistar rats. Two weeks after STZ injection, diabetic rats were treated daily for 12 weeks with LEF (10 mg/kg), benazepril (10 mg/kg), or a combination of both. Basic parameters (body weight, fasting blood glucose level, and 24 h urinary protein excretion), histopathology, inflammatory [inflammatory cell infiltration (ED-1), monocyte chemoattractant protein-1 (MCP-1), and Toll-like receptor-2 (TLR-2)] and glomerulosclerotic factors [transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF)], and oxidative stress (8-hydroxy-2'-deoxyguanosine, 8-OHdG) were studied.</p><p><strong>Results: </strong>Benazepril or LEF treatment significantly prevented body weight loss and 24 h urinary protein excretion induced by diabetes; combined treatment with LEF and benazepril further improved these parameters compared with giving each drug alone (all p < 0.01). Increased expression of inflammatory (MCP-1 and TLR-2) and glomerulosclerotic (TGF-β1 and CTGF) factors in diabetic rat kidney was reduced by treatment with either LEF or benazepril and was further reduced by the combined administration of the two drugs (p < 0.01). These effects were accompanied by suppression of urinary 8-OHdG excretion. There was no significant between-group difference in blood glucose level.</p><p><strong>Conclusions: </strong>LEF treatment lessens DN, and combined treatment with LEF and benazepril provides synergistic effects in preventing DN.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 3","pages":"148-56"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000362556","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32363530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Hydrogen sulfide ameliorates high-glucose toxicity in rat peritoneal mesothelial cells by attenuating oxidative stress. 硫化氢通过减轻氧化应激改善大鼠腹膜间皮细胞的高糖毒性。
Pub Date : 2014-01-01 Epub Date: 2014-05-22 DOI: 10.1159/000358436
Ying Lu, Huaying Shen, Xiaosong Shi, Sheng Feng, Zhi Wang, Yongbing Shi

Background/aims: Continuous exposure of the peritoneal membrane to high-glucose (HG) peritoneal dialysis fluids (PDFs) can produce peritoneal mesothelial cells (PMCs) injury. It has been demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator identified after nitric oxide and carbon monoxide, exhibits a potent protective effect on cell activity. We studied the toxic effects of HG PDFs and their reversal by H2S on cultures of rat PMCs.

Methods: Synchronized confluent rat PMCs were incubated with 2.5% glucose PDFs with or without NaHS, an H2S donor. Cell viability was assessed by methyl thiazolyl tetrazolium assay and flow cytometry. The level of phospho-p38 mitogen-activated protein kinase (MAPK) was analyzed by immunoblotting. p53, Bax and Bcl-2 mRNA expressions by rat PMCs were detected by real-time PCR. The levels of reactive oxygen species (ROS), superoxide dismutase (SOD) activity and caspase-3 activity were measured.

Results: Exposure of rat PMCs to 2.5% glucose PDFs for 24 h resulted in a significant induction of apoptosis, which was attenuated by NaHS. NaHS also restored the 2.5% glucose PDF-induced increase in phospho-p38 MAPK (indices of cellular toxicity). Further investigation of the apoptotic mechanisms in rat PMCs demonstrated that HG activated caspase-3 and upregulated Bax, while it downregulated Bcl-2. All the above responses were prevented by pretreatment with NaHS. Moreover, NaHS reversed the 2.5% glucose PDF-induced increase in ROS generation and decrease in SOD activity.

Conclusions: These findings suggest that HG PDFs significantly inhibit rat PMC viability, leading to peritoneal injury. H2S exhibits a potent anti-apoptotic ability by attenuating oxidative stress and inhibiting caspase-3 activation, which in turn restores peritoneal injury.

背景/目的:腹膜持续暴露于高糖(HG)腹膜透析液(pdf)可产生腹膜间皮细胞(PMCs)损伤。研究表明,硫化氢(H2S)是继一氧化氮和一氧化碳之后发现的第三种内源性气体介质,对细胞活性具有有效的保护作用。我们研究了汞pdf对大鼠PMCs的毒性作用及其在H2S作用下的逆转作用。方法:同步融合大鼠pmc与含或不含H2S供体NaHS的2.5%葡萄糖pdf孵育。采用甲基噻唑四氮唑法和流式细胞术检测细胞活力。免疫印迹法分析磷酸化-p38丝裂原活化蛋白激酶(MAPK)水平。实时荧光定量PCR检测大鼠pmc中p53、Bax和Bcl-2 mRNA的表达。测定各组活性氧(ROS)水平、超氧化物歧化酶(SOD)活性和caspase-3活性。结果:大鼠PMCs暴露于2.5%葡萄糖pdf 24 h后,细胞凋亡显著诱导,NaHS可减弱凋亡。NaHS还恢复了2.5%葡萄糖pdf诱导的磷酸化p38 MAPK(细胞毒性指标)的增加。对大鼠pmc细胞凋亡机制的进一步研究表明,HG激活caspase-3,上调Bax,下调Bcl-2。NaHS预处理可抑制上述反应。此外,NaHS逆转了2.5%葡萄糖pdf诱导的ROS生成增加和SOD活性降低。结论:这些结果表明,HG pdf显著抑制大鼠PMC活力,导致腹膜损伤。H2S通过减轻氧化应激和抑制caspase-3激活而显示出强大的抗凋亡能力,从而恢复腹膜损伤。
{"title":"Hydrogen sulfide ameliorates high-glucose toxicity in rat peritoneal mesothelial cells by attenuating oxidative stress.","authors":"Ying Lu,&nbsp;Huaying Shen,&nbsp;Xiaosong Shi,&nbsp;Sheng Feng,&nbsp;Zhi Wang,&nbsp;Yongbing Shi","doi":"10.1159/000358436","DOIUrl":"https://doi.org/10.1159/000358436","url":null,"abstract":"<p><strong>Background/aims: </strong>Continuous exposure of the peritoneal membrane to high-glucose (HG) peritoneal dialysis fluids (PDFs) can produce peritoneal mesothelial cells (PMCs) injury. It has been demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator identified after nitric oxide and carbon monoxide, exhibits a potent protective effect on cell activity. We studied the toxic effects of HG PDFs and their reversal by H2S on cultures of rat PMCs.</p><p><strong>Methods: </strong>Synchronized confluent rat PMCs were incubated with 2.5% glucose PDFs with or without NaHS, an H2S donor. Cell viability was assessed by methyl thiazolyl tetrazolium assay and flow cytometry. The level of phospho-p38 mitogen-activated protein kinase (MAPK) was analyzed by immunoblotting. p53, Bax and Bcl-2 mRNA expressions by rat PMCs were detected by real-time PCR. The levels of reactive oxygen species (ROS), superoxide dismutase (SOD) activity and caspase-3 activity were measured.</p><p><strong>Results: </strong>Exposure of rat PMCs to 2.5% glucose PDFs for 24 h resulted in a significant induction of apoptosis, which was attenuated by NaHS. NaHS also restored the 2.5% glucose PDF-induced increase in phospho-p38 MAPK (indices of cellular toxicity). Further investigation of the apoptotic mechanisms in rat PMCs demonstrated that HG activated caspase-3 and upregulated Bax, while it downregulated Bcl-2. All the above responses were prevented by pretreatment with NaHS. Moreover, NaHS reversed the 2.5% glucose PDF-induced increase in ROS generation and decrease in SOD activity.</p><p><strong>Conclusions: </strong>These findings suggest that HG PDFs significantly inhibit rat PMC viability, leading to peritoneal injury. H2S exhibits a potent anti-apoptotic ability by attenuating oxidative stress and inhibiting caspase-3 activation, which in turn restores peritoneal injury.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 3","pages":"157-65"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000358436","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32370768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Ischemia/reperfusion of unilateral kidney exaggerates aging-induced damage to the heart and contralateral kidney. 单侧肾脏缺血/再灌注加重了衰老对心脏和对侧肾脏的损伤。
Pub Date : 2014-01-01 Epub Date: 2014-07-03 DOI: 10.1159/000362555
Junichiro Kato, Masaaki Nakayama, Wan-Jun Zhu, Takashi Yokoo, Sadayoshi Ito

Aims: We aimed to determine the impact of aging on ischemic acute kidney injury, especially in terms of the pathological mechanisms of kidney and heart crosstalk.

Method: The effects of 45 min of unilateral ischemic reperfusion (IR) of the renal artery on the contralateral kidney and heart were histologically assessed in 7- and 40-week-old SD rats after 7 days.

Results: Glomerular sclerosis, interstitial fibrosis and numbers of ED1 cells were significantly increased in the contralateral kidneys of the 40-, but not the 7-week-old rats. The numbers of ED1 cells in the heart significantly and similarly increased in both groups, but reactive fibrosis after IR was significant only in the 40-week-old rats. The exaggerated profibrotic response induced by aging seemed to be closely associated with the increased number of ED1 cells in the affected area.

Conclusion: Aging could play a major role in exaggerating the pathological processes of inflammation to fibrosis in remote organs including the heart and the nonischemic kidney after IR stimulation of the unilateral kidney.

目的:探讨衰老对缺血性急性肾损伤的影响,特别是肾心串扰的病理机制。方法:观察7、40周龄SD大鼠单侧肾动脉缺血再灌注45min对对侧肾脏和心脏的影响。结果:40周龄大鼠对侧肾脏肾小球硬化、间质纤维化及ED1细胞数量明显增加,7周龄大鼠对侧肾脏无明显差异。两组心脏中ED1细胞的数量均显著增加,但仅在40周龄大鼠中,IR后的反应性纤维化显著增加。衰老诱导的过度纤维化反应似乎与患处ED1细胞数量的增加密切相关。结论:单侧肾脏IR刺激后,衰老在心脏、非缺血肾等远端器官炎症到纤维化的病理过程中起重要作用。
{"title":"Ischemia/reperfusion of unilateral kidney exaggerates aging-induced damage to the heart and contralateral kidney.","authors":"Junichiro Kato,&nbsp;Masaaki Nakayama,&nbsp;Wan-Jun Zhu,&nbsp;Takashi Yokoo,&nbsp;Sadayoshi Ito","doi":"10.1159/000362555","DOIUrl":"https://doi.org/10.1159/000362555","url":null,"abstract":"<p><strong>Aims: </strong>We aimed to determine the impact of aging on ischemic acute kidney injury, especially in terms of the pathological mechanisms of kidney and heart crosstalk.</p><p><strong>Method: </strong>The effects of 45 min of unilateral ischemic reperfusion (IR) of the renal artery on the contralateral kidney and heart were histologically assessed in 7- and 40-week-old SD rats after 7 days.</p><p><strong>Results: </strong>Glomerular sclerosis, interstitial fibrosis and numbers of ED1 cells were significantly increased in the contralateral kidneys of the 40-, but not the 7-week-old rats. The numbers of ED1 cells in the heart significantly and similarly increased in both groups, but reactive fibrosis after IR was significant only in the 40-week-old rats. The exaggerated profibrotic response induced by aging seemed to be closely associated with the increased number of ED1 cells in the affected area.</p><p><strong>Conclusion: </strong>Aging could play a major role in exaggerating the pathological processes of inflammation to fibrosis in remote organs including the heart and the nonischemic kidney after IR stimulation of the unilateral kidney.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 4","pages":"183-90"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000362555","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32478907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Adoptive transfer of bone marrow dendritic cells failed to localize in the renal cortex and to improve renal injury in adriamycin nephropathy. 骨髓树突状细胞过继移植不能定位于肾皮质,也不能改善阿霉素肾病的肾损伤。
Pub Date : 2014-01-01 Epub Date: 2014-02-11 DOI: 10.1159/000358086
Dong Zheng, Lei Wen, Changbin Li, Ai Peng, Qi Cao, Yiping Wang, David Harris

Background and aims: Murine bone marrow (BM) dendritic cells (DCs) can be modulated to be tolerogenic by cytokines, such as interleukin (IL)-10 and transforming growth factor (TGF)-β, and may play a regulatory role and sustain immune hemostasis in cognate kidney disease. However, it is unknown whether BM-DCs can be used to protect against renal injury in murine Adriamycin nephropathy (AN).

Methods: In this study, by adoptive in vivo transfer of BM-DCs, including immature DCs, mature DCs (lipopolysaccharide-stimulated DCs) and BM regulatory DCs (IL-10/TGF-β-modified DCs, DCregs), we addressed the potential benefits of BM-DCs in chronic kidney disease.

Results: We found that after adoptive transfer of DCregs, renal injury, including glomerulosclerosis, interstitial fibrosis and tubular atrophy, was not changed compared to AN controls. Correspondingly, renal functions measured by serum creatinine, 12-hour urine protein and creatinine clearance were also not improved by transfusion with DCregs compared to AN controls.

Conclusion: This study showed that the adoptive transfer of BM-DCs was unable to improve renal injury in an AN model, and this failure related to their inability to access the kidney.

背景与目的:小鼠骨髓树突状细胞(dc)可受白细胞介素(IL)-10和转化生长因子(TGF)-β等细胞因子的调节而产生耐受性,并可能在同源肾病中发挥调节作用并维持免疫止血。然而,目前尚不清楚bm - dc是否可用于防止小鼠阿霉素肾病(AN)的肾损伤。方法:在本研究中,我们通过采用体内转移的BM- dc,包括未成熟的dc,成熟的dc(脂多糖刺激的dc)和BM调节的dc (IL-10/TGF-β修饰的dc, DCregs),探讨了BM- dc在慢性肾脏疾病中的潜在益处。结果:我们发现,与AN对照组相比,DCregs过继移植后,肾损伤,包括肾小球硬化、间质纤维化和肾小管萎缩没有改变。相应地,与AN对照组相比,输血DCregs也没有改善血清肌酐、12小时尿蛋白和肌酐清除率测量的肾功能。结论:本研究表明,在an模型中,bm - dc的过继性转移不能改善肾损伤,这种失败与它们无法进入肾脏有关。
{"title":"Adoptive transfer of bone marrow dendritic cells failed to localize in the renal cortex and to improve renal injury in adriamycin nephropathy.","authors":"Dong Zheng,&nbsp;Lei Wen,&nbsp;Changbin Li,&nbsp;Ai Peng,&nbsp;Qi Cao,&nbsp;Yiping Wang,&nbsp;David Harris","doi":"10.1159/000358086","DOIUrl":"https://doi.org/10.1159/000358086","url":null,"abstract":"<p><strong>Background and aims: </strong>Murine bone marrow (BM) dendritic cells (DCs) can be modulated to be tolerogenic by cytokines, such as interleukin (IL)-10 and transforming growth factor (TGF)-β, and may play a regulatory role and sustain immune hemostasis in cognate kidney disease. However, it is unknown whether BM-DCs can be used to protect against renal injury in murine Adriamycin nephropathy (AN).</p><p><strong>Methods: </strong>In this study, by adoptive in vivo transfer of BM-DCs, including immature DCs, mature DCs (lipopolysaccharide-stimulated DCs) and BM regulatory DCs (IL-10/TGF-β-modified DCs, DCregs), we addressed the potential benefits of BM-DCs in chronic kidney disease.</p><p><strong>Results: </strong>We found that after adoptive transfer of DCregs, renal injury, including glomerulosclerosis, interstitial fibrosis and tubular atrophy, was not changed compared to AN controls. Correspondingly, renal functions measured by serum creatinine, 12-hour urine protein and creatinine clearance were also not improved by transfusion with DCregs compared to AN controls.</p><p><strong>Conclusion: </strong>This study showed that the adoptive transfer of BM-DCs was unable to improve renal injury in an AN model, and this failure related to their inability to access the kidney.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 1","pages":"8-15"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000358086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32114674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Role of reactive oxygen species-mediated endoplasmic reticulum stress in contrast-induced renal tubular cell apoptosis. 活性氧介导的内质网应激在造影剂诱导的肾小管细胞凋亡中的作用。
Pub Date : 2014-01-01 Epub Date: 2014-10-24 DOI: 10.1159/000366063
Yifei Yang, Dingwei Yang, Dingping Yang, Ruhan Jia, Guohua Ding

Background: Renal tubular cell apoptosis is a key mechanism of contrast-induced acute kidney injury. It has been reported that endoplasmic reticulum (ER) stress is the underlying mechanism of high osmolar contrast-induced renal tubular cell apoptosis. Whether ER stress is involved in low osmolar contrast-induced renal tubular cell injury remains unclear. In the present study, the roles of ER stress in iopromide-induced (a low osmolar contrast) renal tubular cell apoptosis and the effects of N-acetylcysteine (NAC) on ER stress were investigated.

Methods: NRK-52E cells were exposed to different concentrations of iopromide [50, 100 and 150 mg iodine (I)/ml] for 4 h. In a separate experiment, NRK-52E cells were exposed to iopromide (100 mg I/ml, 4 h) with or without NAC (10 mmol/l). NAC was added 1 h before incubation with iopromide. Apoptosis was determined by Hoechst staining and flow cytometry. The intracellular formation of reactive oxygen species (ROS) was detected by confocal microscopy with fluorescent probe CM-H2DCFDA. The expression of glucose-regulated protein 78 (GRP78) and CAAT/enhancer-binding protein homologous protein (CHOP) was determined by Western blot.

Results: Iopromide induced NRK-52E cell apoptosis in a concentration-dependent manner. The intracellular ROS production increased significantly following iopromide exposure in the NRK-52E cells. Significantly increased expressions of GRP78 and CHOP were observed in the NRK-52E cells exposed to iopromide for 4 h; NAC attenuated iopromide-induced NRK-52E cell apoptosis by inhibiting the overproduction of intracellular ROS and subsequently suppressing the overexpression of GRP78 and CHOP.

Conclusion: ROS-mediated ER stress is involved in contrast-induced renal tubular cell apoptosis.

背景:肾小管细胞凋亡是造影剂诱导急性肾损伤的重要机制。据报道,内质网应激是高渗造影剂诱导肾小管细胞凋亡的潜在机制。内质网应激是否参与低渗透压造影剂诱导的肾小管细胞损伤尚不清楚。本研究探讨内质网应激在碘丙胺诱导的肾小管细胞凋亡中的作用以及n -乙酰半胱氨酸(NAC)对内质网应激的影响。方法:将NRK-52E细胞分别暴露于不同浓度的碘酰[50、100和150 mg碘(I)/ml]中4 h,在另一个实验中,NRK-52E细胞分别暴露于碘酰(100 mg I/ml, 4 h)和NAC (10 mmol/l)。在碘丙胺孵育前1 h加入NAC。采用Hoechst染色和流式细胞术检测细胞凋亡。用荧光探针CM-H2DCFDA共聚焦显微镜检测细胞内活性氧(ROS)的形成。Western blot检测葡萄糖调节蛋白78 (GRP78)和CAAT/增强子结合蛋白同源蛋白(CHOP)的表达。结果:碘丙胺诱导NRK-52E细胞凋亡呈浓度依赖性。NRK-52E细胞暴露于碘丙胺后,细胞内ROS生成显著增加。暴露于碘丙胺4 h的NRK-52E细胞中GRP78和CHOP的表达显著增加;NAC通过抑制细胞内ROS的过量产生,进而抑制GRP78和CHOP的过度表达,从而减弱碘丙胺诱导的NRK-52E细胞凋亡。结论:ros介导的内质网应激参与造影剂诱导的肾小管细胞凋亡。
{"title":"Role of reactive oxygen species-mediated endoplasmic reticulum stress in contrast-induced renal tubular cell apoptosis.","authors":"Yifei Yang,&nbsp;Dingwei Yang,&nbsp;Dingping Yang,&nbsp;Ruhan Jia,&nbsp;Guohua Ding","doi":"10.1159/000366063","DOIUrl":"https://doi.org/10.1159/000366063","url":null,"abstract":"<p><strong>Background: </strong>Renal tubular cell apoptosis is a key mechanism of contrast-induced acute kidney injury. It has been reported that endoplasmic reticulum (ER) stress is the underlying mechanism of high osmolar contrast-induced renal tubular cell apoptosis. Whether ER stress is involved in low osmolar contrast-induced renal tubular cell injury remains unclear. In the present study, the roles of ER stress in iopromide-induced (a low osmolar contrast) renal tubular cell apoptosis and the effects of N-acetylcysteine (NAC) on ER stress were investigated.</p><p><strong>Methods: </strong>NRK-52E cells were exposed to different concentrations of iopromide [50, 100 and 150 mg iodine (I)/ml] for 4 h. In a separate experiment, NRK-52E cells were exposed to iopromide (100 mg I/ml, 4 h) with or without NAC (10 mmol/l). NAC was added 1 h before incubation with iopromide. Apoptosis was determined by Hoechst staining and flow cytometry. The intracellular formation of reactive oxygen species (ROS) was detected by confocal microscopy with fluorescent probe CM-H2DCFDA. The expression of glucose-regulated protein 78 (GRP78) and CAAT/enhancer-binding protein homologous protein (CHOP) was determined by Western blot.</p><p><strong>Results: </strong>Iopromide induced NRK-52E cell apoptosis in a concentration-dependent manner. The intracellular ROS production increased significantly following iopromide exposure in the NRK-52E cells. Significantly increased expressions of GRP78 and CHOP were observed in the NRK-52E cells exposed to iopromide for 4 h; NAC attenuated iopromide-induced NRK-52E cell apoptosis by inhibiting the overproduction of intracellular ROS and subsequently suppressing the overexpression of GRP78 and CHOP.</p><p><strong>Conclusion: </strong>ROS-mediated ER stress is involved in contrast-induced renal tubular cell apoptosis.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"128 1-2","pages":"30-6"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000366063","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32782355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease. 分化抑制剂3,一种转录因子,调节高脂血症相关的肾脏疾病。
Pub Date : 2014-01-01 Epub Date: 2014-05-16 DOI: 10.1159/000362452
Dominika Nackiewicz, Paromita Dey, Barbara Szczerba, Saleh Mohammad, Jennifer L Kaplan, Coleen A McNamara, Umesh S Deshmukh, Harini Bagavant

Background: Lipoprotein abnormalities are associated with a rapid decline in renal function in patients of chronic kidney disease. In addition, hyperlipidemia is associated with an increased risk of developing renal insufficiency. The underlying molecular mechanisms for these clinical findings are unclear. We have previously reported a role for inhibitor of differentiation 3 (ID3), a transcription factor, in regulating kidney disease in hyperlipidemia. Introducing a genetic deficiency of Id3 in spontaneously hyperlipidemic apolipoprotein E knockout (Apoe(-/-)) mice led to accelerated mesangioproliferative glomerulonephritis. The present study was carried out to further investigate the contribution of ID3 in hyperlipidemia-associated kidney disease.

Methods: Female C57BL/6 mice that were ID3-sufficient wild-type (WT) or ID3-deficient (Id3(-/-)) were fed a Western diet and evaluated for proteinuria, glomerular pathology, and immune infiltrating cells. Primary mesangial cell lines were generated from both mouse strains and stimulated with oxidized phospholipids. Cytokines and chemokines produced were measured by multiplex assays, ELISA, and QPCR. Glomerular isolates were studied for CXCL1 expression by QPCR.

Results: Id3(-/-) mice on a Western diet developed accelerated proteinuria and mesangioproliferative glomerulonephritis compared to WT controls. In vitro, Id3(-/-) glomerular mesangial cell lines produced higher levels of the monocyte chemoattractant CXCL1 in response to oxidized phospholipids. This was consistent with the rapid increase in glomerular CXCL1 expression followed by macrophage infiltration in Id3(-/-) mice fed a Western diet.

Conclusions: A functional ID3 influences susceptibility to kidney disease and prevents glomerular injury by regulating local chemokine production and inflammatory cell recruitment.

背景:脂蛋白异常与慢性肾病患者肾功能的快速下降有关。此外,高脂血症与发展为肾功能不全的风险增加有关。这些临床发现的潜在分子机制尚不清楚。我们之前报道了分化抑制剂3 (ID3),一种转录因子,在调节高脂血症肾脏疾病中的作用。在自发性高脂血症载脂蛋白E基因敲除(Apoe(-/-))小鼠中引入Id3基因缺陷,导致血管增生性肾小球肾炎加速。本研究旨在进一步探讨ID3在高脂血症相关肾脏疾病中的作用。方法:将Id3充足野生型(WT)和Id3缺乏型(Id3(-/-))雌性C57BL/6小鼠喂食西式饮食,观察其蛋白尿、肾小球病理和免疫浸润细胞的变化。用氧化磷脂刺激这两种小鼠系膜细胞系产生原代系膜细胞系。产生的细胞因子和趋化因子通过多重检测、ELISA和QPCR检测。用QPCR方法研究肾小球分离株CXCL1的表达。结果:与WT对照组相比,西式饮食的Id3(-/-)小鼠出现了加速的蛋白尿和系血管增殖性肾小球肾炎。在体外实验中,Id3(-/-)肾小球系膜细胞系对氧化磷脂产生更高水平的单核细胞趋化剂CXCL1。这与饲喂西方饮食的Id3(-/-)小鼠在巨噬细胞浸润后肾小球CXCL1表达迅速增加是一致的。结论:功能性ID3通过调节局部趋化因子的产生和炎症细胞的募集,影响肾脏疾病的易感性,并预防肾小球损伤。
{"title":"Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.","authors":"Dominika Nackiewicz,&nbsp;Paromita Dey,&nbsp;Barbara Szczerba,&nbsp;Saleh Mohammad,&nbsp;Jennifer L Kaplan,&nbsp;Coleen A McNamara,&nbsp;Umesh S Deshmukh,&nbsp;Harini Bagavant","doi":"10.1159/000362452","DOIUrl":"https://doi.org/10.1159/000362452","url":null,"abstract":"<p><strong>Background: </strong>Lipoprotein abnormalities are associated with a rapid decline in renal function in patients of chronic kidney disease. In addition, hyperlipidemia is associated with an increased risk of developing renal insufficiency. The underlying molecular mechanisms for these clinical findings are unclear. We have previously reported a role for inhibitor of differentiation 3 (ID3), a transcription factor, in regulating kidney disease in hyperlipidemia. Introducing a genetic deficiency of Id3 in spontaneously hyperlipidemic apolipoprotein E knockout (Apoe(-/-)) mice led to accelerated mesangioproliferative glomerulonephritis. The present study was carried out to further investigate the contribution of ID3 in hyperlipidemia-associated kidney disease.</p><p><strong>Methods: </strong>Female C57BL/6 mice that were ID3-sufficient wild-type (WT) or ID3-deficient (Id3(-/-)) were fed a Western diet and evaluated for proteinuria, glomerular pathology, and immune infiltrating cells. Primary mesangial cell lines were generated from both mouse strains and stimulated with oxidized phospholipids. Cytokines and chemokines produced were measured by multiplex assays, ELISA, and QPCR. Glomerular isolates were studied for CXCL1 expression by QPCR.</p><p><strong>Results: </strong>Id3(-/-) mice on a Western diet developed accelerated proteinuria and mesangioproliferative glomerulonephritis compared to WT controls. In vitro, Id3(-/-) glomerular mesangial cell lines produced higher levels of the monocyte chemoattractant CXCL1 in response to oxidized phospholipids. This was consistent with the rapid increase in glomerular CXCL1 expression followed by macrophage infiltration in Id3(-/-) mice fed a Western diet.</p><p><strong>Conclusions: </strong>A functional ID3 influences susceptibility to kidney disease and prevents glomerular injury by regulating local chemokine production and inflammatory cell recruitment.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 3","pages":"141-7"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000362452","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32362018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Nephron Experimental Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1